Related Experiment Video
Updated: Apr 2, 2026

Wet Chemistry and Peptide Immobilization on Polytetrafluoroethylene for Improved Cell-adhesion
Published on: August 15, 2016
Trypsin and trypsin inhibitor bind PAMAM nanoparticles: Effect of hydrophobicity on protein-polymer conjugation
P Chanphai1, H A Tajmir-Riahi1
1Department of Chemistry-Biochemistry and Physics, University of Québec at Trois Rivières, C.P. 500, TR, Quebec G9A 5H7, Canada.
Abstract:
Protein-polymer conjugates are widely used in therapeutic drug delivery. We report the bindings of trypsin (Try) and trypsin inhibitor (Tryi) with polyamidoamine (PAMAM-G4) dendrimer at physiological conditions, using thermodynamic analysis, UV-Visible and Fourier transform infrared (FTIR) spectroscopic methods. Thermodynamic parameters ΔS, ΔH and ΔG showed protein-PAMAM bindings occur via H-bonding and van der Waals contacts with trypsin inhibitor forming more stable conjugate than trypsin. PAMAM complexation induces more perturbations of trypsin inhibitor structure than trypsin with reduction of protein alpha-helix and major changes of beta-structures. The negative value of ΔG indicates spontaneous protein-polymer conjugation at room temperature.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Site-Targeted Drug Delivery Systems: Polymeric Carriers

